V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007313 | 250009711 | 1.56 | 61 | Disease modification (D) | 2014-02-24 | 2014-03-19 | Docetaxel 75mg/m2 (21 day) | null | N | 250031778 | PEMETREXED |
| 250007314 | 250005145 | 1.77 | 60.9 | Disease modification (D) | 2018-07-23 | 2018-08-19 | CHOP R - 21 days | 02 | N | 250031781 | RUXOLITINIB |
| 250007315 | 250005146 | null | null | Palliative (P) | null | 2014-11-08 | Trial Unspecified | null | null | 250031782 | BUSULPHAN |
| 250007316 | 250005146 | 1.55 | 84.6 | Palliative (P) | 2018-02-23 | 2018-02-25 | RUXOLITINIB | 02 | N | 250031782 | IMATINIB |
| 250007317 | 250005147 | null | 68 | Disease modification (D) | 2014-07-26 | 2014-07-26 | BUSULFAN | null | N | 250031785 | RUXOLITINIB |
| 250007318 | 250005147 | 1.64 | 72 | Disease modification (D) | 2017-08-10 | 2017-08-20 | DA 3 + 10 | N | N | 250031785 | DA |
| 250007319 | 250005148 | 1.87 | 0 | Palliative (P) | null | 2017-12-29 | RUXOLITINIB | N | N | 250031791 | PILOT TRIAL |
| 250007320 | 250005149 | 1.73 | 49.8 | null | 2015-01-02 | 2015-01-02 | Bevacizumab | N | N | 250031793 | PEG INTERFERON |
| 250007321 | 250005150 | 1.72 | 0 | Palliative (P) | 2014-08-16 | 2014-11-08 | RUXOLITINIB | N | N | 250031800 | METHOTREXATE INTRATHECAL |
| 250007322 | 250005151 | 1.58 | 0 | Disease modification (D) | 2017-09-24 | 2018-01-26 | AML17 TRIAL | N | N | 250031801 | ANAGRELIDE |
| 250007323 | 250005152 | 1.83 | 103.2 | Palliative (P) | 2016-11-23 | 2016-12-03 | RUXOLITINIB | Y | N | 250031807 | RUXOLITINIB |
| 250007324 | 250005153 | 1.63 | null | Curative (C) | null | 2014-05-31 | RUXOLITINIB | N | N | 250031808 | RITUXIMAB |
| 250007325 | 250009714 | 1.65 | 76.2 | Palliative (P) | 2013-04-19 | 2013-04-26 | ETOPOSIDE | 2 | N | 250031809 | AZACITIDINE |
| 250007326 | 250005154 | 1.64 | null | Not known (9) | 2014-10-28 | 2014-10-30 | Rituximab | 02 | N | 250031811 | BENDAMUSTINE + RITUXIMAB |
| 250007327 | 250005155 | 1.59 | 98.4 | null | null | 2013-02-28 | Trial Unspecified | 2 | N | 250031812 | IMATINIB |
| 250007328 | 250005156 | 1.65 | 91.5 | Palliative (P) | 2014-12-10 | 2014-12-10 | Rituximab | N | N | 250031814 | CISPLATIN + GEMCITABINE |
| 250007329 | 250005157 | 1.52 | null | Disease modification (D) | 2013-01-10 | 2013-01-15 | PEG INTERFERON | 2 | N | 250031817 | RUXOLITINIB |
| 250007330 | 250005158 | 1.81 | 0 | Palliative (P) | 2017-08-21 | 2017-08-27 | RUXOLITINIB | N | N | 250031821 | RITUXIMAB |
| 250007331 | 250005159 | 1.8 | null | Disease modification (D) | 2018-05-28 | 2018-05-28 | RUXOLITINIB | 2 | N | 250031822 | RUXOLITINIB |
| 250007332 | 250005160 | 1.8 | 70.2 | Curative (C) | 2013-06-05 | 2013-06-05 | Rituximab | 2 | N | 250031823 | RUXOLITINIB |
| 250007333 | 250005161 | 1.52 | 66.1 | Palliative (P) | 2016-02-07 | 2016-02-07 | RUXOLITINIB | 02 | null | 250031824 | PEG INTERFERON |
| 250007334 | 250005162 | null | null | Not known (9) | null | 2016-03-07 | RUXOLITINIB | N | N | 250031825 | RUXOLITINIB |
| 250007335 | 250005163 | null | 0 | Palliative (P) | 2013-04-04 | 2013-04-06 | RUXOLITINIB | 02 | N | 250031828 | RUXOLITINIB |
| 250007336 | 250005164 | 1.61 | null | Disease modification (D) | 2013-09-23 | 2013-09-23 | RUXOLITINIB | 02 | N | 250031830 | BUSULPHAN |
| 250007338 | 250005166 | 0 | 0 | Curative (C) | 2014-06-05 | 2014-06-19 | RUXOLITINIB | N | N | 250031836 | ANAGRELIDE |
| 250007339 | 250005167 | 1.81 | null | Not known (9) | 2013-05-14 | 2013-05-14 | Rituximab | N | N | 250031837 | BUSULPHAN |
| 250007341 | 250005169 | 1.89 | null | Disease modification (D) | 2013-08-08 | 2013-08-08 | RUXOLITINIB | Y | N | 250031844 | TRIAL |
| 250007343 | 250005171 | 1.82 | 65.5 | Disease modification (D) | 2014-11-28 | 2014-11-28 | IMATINIB | N | N | 250031848 | THALIDOMIDE |
| 250007344 | 250005172 | 1.75 | 0 | Curative (C) | 2016-06-19 | 2016-07-05 | Rituximab | N | N | 250031850 | RUXOLITINIB |
| 250007345 | 250009715 | 1.8 | 67.2 | Palliative (P) | 2013-03-13 | 2013-04-01 | IMATINIB | N | N | 250031851 | BUSULPHAN |
| 250007346 | 250005173 | 1.56 | 81.95 | Palliative (P) | 2013-11-13 | 2013-11-26 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 250031853 | RUXOLITINIB |
| 250007347 | 250005174 | 1.83 | 65 | Disease modification (D) | 2017-02-17 | 2017-09-01 | CYTARABINE + ETOPOSIDE + IDARUBICIN | Y | N | 250031855 | LENALIDOMIDE |
| 250007348 | 250005174 | 1.76 | null | Palliative (P) | 2018-01-11 | 2018-01-17 | Trial Unspecified | 02 | N | 250031855 | CVD |
| 250007349 | 250005175 | null | 104.6 | Palliative (P) | 2015-03-26 | 2015-04-04 | DA | N | N | 250031862 | RUXOLITINIB |
| 250007350 | 250005176 | null | 57 | Palliative (P) | 2011-09-28 | 2013-11-16 | DA | N | N | 250031864 | RUXOLITINIB |
| 250007351 | 250005177 | null | 102 | Palliative (P) | 2015-09-29 | 2015-09-29 | RUXOLITINIB | N | null | 250031865 | RUXOLITINIB |
| 250007352 | 250005177 | null | null | null | 2013-06-11 | 2013-06-11 | FIGARO TRIAL | N | N | 250031865 | RUXOLITINIB |
| 250007353 | 250011603 | 0 | 0 | Palliative (P) | 2017-03-05 | 2017-10-23 | CYCLOPHOSPHAMIDE | N | N | 250031868 | RUXOLITINIB |
| 250007354 | 250005178 | 0 | 84.2 | Disease modification (D) | 2018-01-06 | 2018-01-12 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | 250031870 | IMATINIB |
| 250007355 | 250005178 | null | 62.5 | null | 2015-04-20 | 2015-04-20 | Trial Unspecified | N | N | 250031870 | IMATINIB |
| 250007356 | 250005179 | 1.77 | 0 | Disease modification (D) | 2018-03-13 | 2018-03-25 | RUXOLITINIB | N | N | 250031873 | RUXOLITINIB |
| 250007357 | 250005180 | 1.61 | 81.7 | Palliative (P) | 2015-01-16 | 2015-01-16 | Azacitidine | 2 | null | 250031879 | RUXOLITINIB |
| 250007358 | 250005181 | 0 | 69.4 | Curative (C) | 2015-03-14 | 2015-04-11 | Capecitabine + Oxaliplatin 14day | N | 2 | 250031884 | TRIAL |
| 250007359 | 250005181 | 1.53 | 67.6 | Adjuvant (A) | 2014-07-13 | 2014-07-13 | RUXOLITINIB | N | null | 250031884 | RITUXIMAB |
| 250007360 | 250011604 | null | 73 | Adjuvant (A) | 2014-12-19 | 2015-01-13 | RUXOLITINIB | null | N | 250031891 | BORTEZOMIB + THALIDOMIDE |
| 250007361 | 250005182 | 1.67 | 80 | Palliative (P) | 2015-11-20 | 2015-11-20 | Rituximab | N | N | 250031893 | BUSULPHAN |
| 250007362 | 250005182 | 1.73 | 95.4 | Adjuvant (A) | 2013-06-24 | 2013-06-27 | Cytarabine Low Dose | 2 | N | 250031893 | RUXOLITINIB |
| 250007363 | 250005182 | 1.85 | null | Curative (C) | 2014-02-08 | 2014-02-08 | PEG INTERFERON | 1 | null | 250031893 | RITUXIMAB |
| 250007364 | 250012380 | null | null | Palliative (P) | 2018-04-14 | 2018-04-14 | RUXOLITINIB | 02 | N | 250031897 | RUXOLITINIB |
| 250007365 | 250012703 | 1.7 | 80.9 | Palliative (P) | 2016-01-06 | 2016-01-12 | RUXOLITINIB | N | N | 250031900 | RUXOLITINIB |